CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
17.43
2.05%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.13
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Cross Country Healthcare Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 17.08
Open* 17.01
1-Year Change* -25.66%
Day's Range* 17.01 - 17.44
52 wk Range 15.65-31.82
Average Volume (10 days) 267.61K
Average Volume (3 months) 8.03M
Market Cap 761.02M
P/E Ratio 7.67
Shares Outstanding 35.15M
Revenue 2.23B
EPS 2.82
Dividend (Yield %) N/A
Beta 0.78
Next Earnings Date Feb 20, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 19, 2024 17.43 0.73 4.37% 16.70 17.46 16.70
Apr 18, 2024 17.08 0.24 1.43% 16.84 17.13 16.66
Apr 17, 2024 16.83 -0.51 -2.94% 17.34 17.44 16.82
Apr 16, 2024 17.16 0.13 0.76% 17.03 17.62 16.96
Apr 15, 2024 17.67 0.21 1.20% 17.46 17.70 17.23
Apr 12, 2024 17.50 0.21 1.21% 17.29 17.58 17.25
Apr 11, 2024 17.45 0.19 1.10% 17.26 17.67 17.26
Apr 10, 2024 17.60 -0.27 -1.51% 17.87 17.87 17.33
Apr 9, 2024 18.21 0.27 1.51% 17.94 18.35 17.94
Apr 8, 2024 18.12 0.35 1.97% 17.77 18.40 17.77
Apr 5, 2024 17.75 -0.06 -0.34% 17.81 17.92 17.60
Apr 4, 2024 17.77 -0.17 -0.95% 17.94 18.06 17.67
Apr 3, 2024 17.82 0.31 1.77% 17.51 18.02 17.36
Apr 2, 2024 17.81 -0.34 -1.87% 18.15 18.18 17.46
Apr 1, 2024 18.38 -0.37 -1.97% 18.75 19.05 18.26
Mar 28, 2024 18.64 0.19 1.03% 18.45 18.67 18.08
Mar 27, 2024 18.38 -0.03 -0.16% 18.41 18.57 18.11
Mar 26, 2024 18.36 0.38 2.11% 17.98 18.43 17.98
Mar 25, 2024 18.24 -0.19 -1.03% 18.43 18.52 17.95
Mar 22, 2024 18.37 -0.39 -2.08% 18.76 18.94 18.19

Cross Country Events

Time (UTC) Country Event
Wednesday, May 1, 2024

Time (UTC)

20:00

Country

US

Event

Q1 2024 Cross Country Healthcare Inc Earnings Release
Q1 2024 Cross Country Healthcare Inc Earnings Release

Forecast

-

Previous

-

Time (UTC)

21:00

Country

US

Event

Q1 2024 Cross Country Healthcare Inc Earnings Call
Q1 2024 Cross Country Healthcare Inc Earnings Call

Forecast

-

Previous

-
Tuesday, May 14, 2024

Time (UTC)

16:00

Country

US

Event

Cross Country Healthcare Inc Annual Shareholders Meeting
Cross Country Healthcare Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, May 15, 2024

Time (UTC)

16:00

Country

US

Event

Cross Country Healthcare Inc Annual Shareholders Meeting
Cross Country Healthcare Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, July 31, 2024

Time (UTC)

10:59

Country

US

Event

Q2 2024 Cross Country Healthcare Inc Earnings Release
Q2 2024 Cross Country Healthcare Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2806.61 1676.65 836.417 822.224 816.484
Revenue 2806.61 1676.65 836.417 822.224 816.484
Cost of Revenue, Total 2178.92 1301.65 633.685 618.215 606.921
Gross Profit 627.686 374.999 202.732 204.009 209.563
Total Operating Expense 2537.23 1537.35 845.577 839.913 829.443
Selling/General/Admin. Expenses, Total 333.818 220.075 176.844 183.967 182.434
Depreciation / Amortization 12.576 9.852 12.671 14.075 11.78
Unusual Expense (Income) 11.912 5.768 22.377 23.656 28.308
Operating Income 269.38 139.304 -9.16 -17.689 -12.959
Interest Income (Expense), Net Non-Operating -14.391 -6.866 -2.89 -6.59 -5.654
Other, Net 1.336 0.77 -0.28 0.068 0.418
Net Income Before Taxes 256.325 133.208 -12.33 -24.211 -18.195
Net Income After Taxes 188.461 132.002 -12.142 -55.943 -15.617
Minority Interest 0 0 -0.82 -1.77 -1.234
Net Income Before Extra. Items 188.461 132.002 -12.962 -57.713 -16.851
Net Income 188.461 132.002 -12.962 -57.713 -16.951
Income Available to Common Excl. Extra. Items 188.461 132.002 -12.962 -57.713 -16.851
Income Available to Common Incl. Extra. Items 188.461 132.002 -12.962 -57.713 -16.951
Diluted Net Income 188.461 132.002 -12.962 -57.713 -16.951
Diluted Weighted Average Shares 37.536 37.392 36.088 35.815 35.657
Diluted EPS Excluding Extraordinary Items 5.02081 3.53022 -0.35918 -1.61142 -0.47259
Diluted Normalized EPS 5.25413 3.68308 0.04387 -1.18209 0.04345
Total Extraordinary Items -0.1
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 540.695 622.707 628.218 636.098 753.561
Revenue 540.695 622.707 628.218 636.098 753.561
Cost of Revenue, Total 417.556 483.284 489.276 492.553 583.156
Gross Profit 123.139 139.423 138.942 143.545 170.405
Total Operating Expense 507.229 578.91 578.57 583.923 676.636
Selling/General/Admin. Expenses, Total 82.008 89.186 84.118 81.317 89.201
Depreciation / Amortization 4.432 4.904 3.162 3.214 3.481
Unusual Expense (Income) 3.233 1.536 2.014 6.839 0.798
Operating Income 33.466 43.797 49.648 52.175 76.925
Interest Income (Expense), Net Non-Operating -3.149 -3.69 -3.515 -3.498 -3.857
Other, Net -0.011 0.012 0.217 0.027 1.084
Net Income Before Taxes 30.306 40.119 46.35 48.704 74.152
Net Income After Taxes 21.345 29.436 38.791 34.793 52.894
Minority Interest 0
Net Income Before Extra. Items 21.345 29.436 38.791 34.793 52.894
Net Income 21.345 29.436 38.791 34.793 52.894
Income Available to Common Excl. Extra. Items 21.345 29.436 38.791 34.793 52.894
Income Available to Common Incl. Extra. Items 21.345 29.436 38.791 34.793 52.894
Diluted Net Income 21.345 29.436 38.791 34.793 52.894
Diluted Weighted Average Shares 35.524 36.56 36.921 37.492 37.757
Diluted EPS Excluding Extraordinary Items 0.60086 0.80514 1.05065 0.92801 1.40091
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.66496 0.83597 1.0963 1.05832 1.41598
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 675.673 508.273 183.111 183.357 194.905
Cash and Short Term Investments 3.604 1.036 1.6 1.032 16.019
Cash & Equivalents 3.604 1.036 1.6 1.032 16.019
Total Receivables, Net 659.96 498.951 174.701 174.539 170.314
Accounts Receivable - Trade, Net 641.611 493.91 170.003 169.528 166.128
Prepaid Expenses 11.067 7.648 5.455 6.097 6.208
Other Current Assets, Total 1.042 0.638 1.355 1.689 2.364
Total Assets 947.839 732.809 356.973 382.374 427.003
Property/Plant/Equipment, Total - Net 22.927 23.378 22.9 28.796 13.628
Property/Plant/Equipment, Total - Gross 40.609 41.107 39.913 52.072 47.104
Accumulated Depreciation, Total -17.682 -17.729 -17.013 -23.276 -33.476
Goodwill, Net 163.268 119.49 90.924 101.066 101.06
Intangibles, Net 44.723 48.244 40.731 50.857 75.584
Note Receivable - Long Term 23.058 13.998 13.115 14.273 15.726
Other Long Term Assets, Total 18.19 19.426 6.192 4.025 26.1
Total Current Liabilities 271.64 199.77 93.423 85.465 85.386
Payable/Accrued 109.753 49.877 45.726 43.744
Accrued Expenses 100.368 67.222 37.55 33.525 30.546
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 4.176 0 5.235
Other Current Liabilities, Total 12.822 18.619 5.996 6.214 5.861
Total Liabilities 490.62 435.281 202.598 219.742 209.475
Total Long Term Debt 148.735 176.366 53.408 70.974 77.944
Long Term Debt 148.735 176.366 53.408 70.974 77.944
Deferred Income Tax 0.247 0.19 6.592 7.523 0.095
Minority Interest 0 0.534 0.868 0.67
Other Liabilities, Total 69.998 58.955 48.641 54.912 45.38
Total Equity 457.219 297.528 154.375 162.632 217.528
Common Stock 0.004 0.004 0.004 0.004 0.004
Additional Paid-In Capital 292.876 321.552 310.388 305.643 303.048
Retained Earnings (Accumulated Deficit) 165.726 -22.735 -154.737 -141.775 -84.062
Other Equity, Total -1.387 -1.293 -1.28 -1.24 -1.462
Total Liabilities & Shareholders’ Equity 947.839 732.809 356.973 382.374 427.003
Total Common Shares Outstanding 36.3026 37.0236 36.1773 35.8706 35.6257
Accounts Payable 158.45
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 445.229 505.634 648.612 675.673 660.017
Cash and Short Term Investments 14.301 0.673 0.291 3.604 30.32
Cash & Equivalents 14.301 0.673 0.291 3.604 30.32
Total Receivables, Net 423.419 496.841 636.125 659.96 617.099
Accounts Receivable - Trade, Net 410.373 484.885 627.076 641.611 610.897
Prepaid Expenses 4.779 6.753 10.937 11.067 3.952
Other Current Assets, Total 2.73 1.367 1.259 1.042 8.646
Total Assets 707.739 771.13 920.541 947.839 882.512
Property/Plant/Equipment, Total - Net 28.89 27.15 25.588 22.916 21.805
Property/Plant/Equipment, Total - Gross 46.067 45.287 42.035 37.344 38.402
Accumulated Depreciation, Total -19.805 -20.443 -18.953 -17.682 -19.846
Goodwill, Net 135.43 137.02 141.52 163.268 113.36
Intangibles, Net 57.256 60.171 63.086 44.723 46.743
Other Long Term Assets, Total 18.605 19.209 18.955 18.201 19.834
Total Current Liabilities 183.578 216.027 264.908 271.64 276.79
Payable/Accrued 114.797 139.555 176.881 185.507 192.032
Accrued Expenses 60.202 59.313 73.268 76.737 75.436
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 8.579 17.159 14.759 9.396 9.322
Total Liabilities 238.078 300.782 468.611 490.62 459.803
Total Long Term Debt 0 31 138.443 148.735 129.755
Long Term Debt 0 31 138.443 148.735 129.755
Deferred Income Tax 0.247 0.237
Minority Interest
Other Liabilities, Total 54.5 53.755 65.26 69.998 53.021
Total Equity 469.661 470.348 451.93 457.219 422.709
Common Stock 0.004 0.004 0.004 0.004 0.004
Additional Paid-In Capital 241.732 255.216 258.144 292.876 297.143
Retained Earnings (Accumulated Deficit) 229.319 216.507 195.162 165.726 126.935
Other Equity, Total -1.394 -1.379 -1.38 -1.387 -1.373
Total Liabilities & Shareholders’ Equity 707.739 771.13 920.541 947.839 882.512
Total Common Shares Outstanding 34.689 35.305 35.454 36.3026 36.508
Current Port. of LT Debt/Capital Leases 0 0
Note Receivable - Long Term 22.329 21.946 22.78 23.058 20.753
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 188.461 132.002 -12.142 -55.943 -15.717
Cash From Operating Activities 134.05 -85.618 27.204 5.542 20.997
Cash From Operating Activities 12.576 9.852 12.671 14.075 11.78
Deferred Taxes 5.062 -9.927 -0.932 31.159 -3.41
Non-Cash Items 34.095 19.715 30.457 30.425 35.73
Cash Taxes Paid 82.893 3.608 0.612 0.555 1.043
Cash Interest Paid 12.859 5.773 2.666 4.554 6.34
Changes in Working Capital -106.144 -237.26 -2.85 -14.174 -7.386
Cash From Investing Activities -43.874 -34.046 -4.615 -2.94 -6.678
Capital Expenditures -8.786 -7.17 -4.615 -2.94 -4.597
Other Investing Cash Flow Items, Total -35.088 -26.876 0 0 -2.081
Cash From Financing Activities -87.599 119.094 -22.01 -17.599 -23.767
Financing Cash Flow Items -17.05 -8.583 -2.018 -4.697 -2.643
Issuance (Retirement) of Debt, Net -35.264 127.677 -19.992 -12.902 -16.124
Foreign Exchange Effects -0.009 0.006 -0.011 0.01 -0.07
Net Change in Cash 2.568 -0.564 0.568 -14.987 -9.518
Issuance (Retirement) of Stock, Net -35.285 0 0 -5
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 29.436 188.461 149.67 114.877 61.983
Cash From Operating Activities 46.865 134.05 129.73 -10.897 -29.038
Cash From Operating Activities 4.904 12.576 9.414 6.2 2.719
Non-Cash Items 8.514 34.095 24.232 15.285 7.534
Changes in Working Capital 4.608 -106.144 -56.383 -150.735 -103.702
Cash From Investing Activities -3.496 -43.874 -6.763 -3.848 -2.096
Capital Expenditures -3.678 -8.786 -6.763 -3.848 -2.096
Cash From Financing Activities -46.681 -87.599 -93.674 13.987 31.308
Financing Cash Flow Items -4.521 -17.05 -16.462 -8.949 -8.131
Issuance (Retirement) of Debt, Net -10.4 -35.264 -52.864 22.936 39.439
Foreign Exchange Effects -0.001 -0.009 -0.009 0.001 -0.002
Net Change in Cash -3.313 2.568 29.284 -0.757 0.172
Deferred Taxes -0.597 5.062 2.797 3.476 2.428
Other Investing Cash Flow Items, Total 0.182 -35.088 0 0
Issuance (Retirement) of Stock, Net -31.76 -35.285 -24.348

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Cross Country Company profile

About Cross Country Healthcare, Inc.

Cross Country Healthcare, Inc. is engaged in providing total talent management services, including workforce solutions, contingent staffing, permanent placement, and consultative services. The Company operates through two segments: Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment provides traditional staffing, recruiting, including temporary and permanent placement of travel and local nurse and allied professionals, managed services programs (MSP) services, education healthcare services, in-home care services, and outsourcing services. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Cross Country Healthcare, Inc. revenues increased 100% to $1.68B. Net income totaled $132M vs. loss of $13M. Revenues reflect Nurse and allied staffing segment increase from $757.9M to $1.61B, Physician Staffing segment increase of 4% to $70.9M. Net Income reflects Nurse and allied staffing segment income increase from $75.3M to $205.7M, Unallocated Corporate Overhead segment loss decrease of 19% to $70.8M.

Equity composition

Common Stock $.0001 Par, 3/11, 100M auth., 31,102,682 issd., Insiders control 3.19%. Initial Public Offering 10/25/01, 7,812,500 shares @ $Ca17 by Merrill Lync & Co. *FY'99 = 5 months due to 7/30/99 inception of operations. *NOTE: 5/03, Name changed from Cross Country, FY'01 financials and Q's are restated for discontinued ops.

Industry: Employment Services (NEC)

6551 Park of Commerce Blvd.
BOCA RATON
FLORIDA 33487
US

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

XRP/USD

0.54 Price
+0.420% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,392.09 Price
+0.540% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.40

US100

17,037.80 Price
-1.980% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

64,980.15 Price
+0.250% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading